MUDr. Dana Maňasková

  • medicinman.cz
  • Zájmy a činnosti
  • Nemoci a symptomy
  • Léky, látky a laboratorní testy
  • Postupy, metody a terapie
  • Dietologie a potravinářství
  • P-o-traviny, rostliny aj.
  • Papírování
  • Zajímaví lidé a činnosti
  • Odborná pracoviště
  • Odborné odkazy
  • Obecné odkazy a tipy
  • Kalendář akcí
  • CV a kredity
  • Fantazie, nápady a snění
  • GDPR

Vyhledávání na medicinman.cz
 

leky-latky/ADIPOQ-gen/asociovane-choroby

ADIPOQ

  • Koduje Adiponektin

Polymorfismy genu pro adiponektin

  • Reakce na mononenasycené tuky
  • Gen exprimovaný v tukové tkáni.
    • Reguluje metabolismus tuků
  • Citlivost na inzulin
  • Vliv na jo-jo efekt
  • Hladinu adiponektinu
  • Inconsistently associated with adiponectin levels or diabetes [1]

Common Variants in the Adiponectin Gene (ADIPOQ) Associated With Plasma Adiponectin Levels, Type 2 Diabetes, and Diabetes-Related Quantitative Traits, The Framingham Offspring Study

  • Participants in the Framingham Offspring Study (n = 2,543, 53% women)
    • Glycemic phenotypes and incident diabetes over 28 years of follow-up
    • adiponectin levels were quantified [1]

Adiponectin levels

  • Rs17300539 (-11391G/A)(5' promoter region ); Pnominal [Pn] = 2.6 × 10-8; Pempiric [Pe] = 0.0005 [1] - často genotypizováno
    • Minor A allele
      • Associated with higher adiponectin levels in a meta-analysis of >2,000 individuals [1]
      • Seemed to enhance the ADIPOQ promoter activity and increased transcriptional activity [1]
      • Strongest signal associated with adiponectin levels [1]
    • Each minor allele (MAF = 0.10) increases adiponectin levels by 1.63 µg/ml
      • Each 1 µg/ml increase in adiponectin levels decreases diabetes risk incidence by 8.1% (24) [1]
        • Had <10% power to detect the effect of rs17300539 on diabetes incidence [1]
  • Rs266729 (-11377C/G) - často genotypyzováno - kontroverzní výsledky studií [1]
  • Rs822387 (5' promoter region ); Pn = 3.8 × 10-5; Pe = 0.001) [1]
    • Minor C allele associated with higher adiponectin levels, confirming the report of Heid et al. [1]
  • Rs6773957 (A 3'-untranslated region 3'UTR) Pn = 4.4 × 10-4; Pe = 0.005 [1]
    • Strongest signal in this region of ADIPOQ
    • Other SNPs in the 3'UTR nominally associated with adiponectin levels [1]
  • Rs6444175 [1]
    • A allele associated with higher adiponectin levels [1]
  • Rs1501299 (+276G/T) [1]
    • Minor T allele was associated with higher adiponectin levels
    • In vitro data has not supported a functional role for rs1501299 in adiponectin expression
      • Might be a marker, through linkage disequilibrium, of a functional variant in the 3'UTR region [1]

Diabetes

  • Rs17366743, Y111H - A nonsynonymous SNP - missense SNP of ADIPOQ - associated with [1]
    • Diabetes incidence (HR 1.94 [95% CI 1.16–3.25] for the minor C allele; Pn = 0.01) [1]
    • Higher mean fasting glucose over 28 years of follow-up (Pn = 0.0004; Pe = 0.004) [1]
    • No other significant associations were found with other adiposity and metabolic phenotypes [1]
    • Y›H change at codon 111 in exon 3 of ADIPOQ [1]
    • Amino acid change from a Tyr (T allele) into a His (C allele) in position 111 of the adiponectin protein
      • Hinge between the collagen and the globular domains of adiponectin
      • Believed to disrupt the exonic splicing enhancer
        • Could influence alternative splicing of the message
    • Does not influence the level of the circulating adiponectin
      • Could influence the functionality of the protein
        • Decrease the insulin-sensitizing role of adiponectin
          • Carrier individuals at higher risk of diabetes [1]
    • The minor C allele in Framingham (3.6%)
      • More frequent in HapMap CEU subjects (7.5%) [1]
    • Diabetes survival and mean glucose were associated [1]

Life Test neznámého / neznámých polymorfismů ADIPOQ

Snad AA / AG ? - rs17300539 (-11391G/A) ???

  • Alespoň jednou vzácnou kopií genu ADIPOQ pravděpodobně úspěšněji zabrání tzv. jojo efektu po snížení tělesné
hmotnosti
  • Asi 20 % lidí v populaci

Genotyp GG čeho ?

  • Cca 80 % populace má běžný genotyp GG
  • Musí věnovat zachování tělesné hmotnosti po zhubnutí větší úsilí
  • Velmi pravděpodobné, že po zhubnutí se začne tělesná hmotnost opět zvyšovat
    • Nejčastější chyba: snaha hubnout hladověním !
  • Důležité jsou zdravé stravovací návyky - trvalé !!!
DM má GG dle LifeTestu


O úroveň výše

Poslední aktualizace: 8. 10. 2018 13:28:05
© Dana Maňasková, metabalance.cz
e-mail